ZADAXIN (thymalfasin) is well tolerated. During clinical experience involving over 2000 individuals with various diseases distributed over all age groups, no clinically significant adverse reactions attributable to thymosin alpha 1 administration were reported (see table below).
|Disease||Adverse Event Rate|
|Viral Infection||Chronic hepatitis B Chronic hepatitis C Human immunodeficiency||< 1% drug related adverse events for all indications|
|Cancer||Non-small cell lung cancer Melanoma|
|Vaccine adjuvant||Hepatitis B vaccine Influenza vaccine|
|Immune disorders||Autoimmune liver disease Primary immune deficiency|
Adverse experiences have been infrequent and mild, consisting primarily of local discomfort at the injection site, and rare instances of erythema, transient muscle atrophy, polyarthralgia combined with hand edema, and rash.
Read the Zadaxin (thymalfasin) Side Effects Center for a complete guide to possible side effects
Drug Interactions and Incompatibilities
Interactions between ZADAXIN (thymalfasin) and other drugs have not been fully evaluated. Caution should be exercised when administering ZADAXIN (thymalfasin) therapy in combination with other immunomodulating drugs ZADAXIN (thymalfasin) should not be mixed with any other drug
Last reviewed on RxList: 3/3/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Zadaxin Information
Report Problems to the Food and Drug Administration
Find out what women really need.